Hypertrophic Obstructive Cardiomyopathy with SAM Phenomenon: A Case Report and Literature Review

Mei-Lian Cai1,2, Guo-Qiang Zhong1

  • 1Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning City, China.

Cardiology and Cardiovascular Medicine
|December 30, 2022
PubMed

Insights

Alcohol septal ablation effectively treated hypertrophic obstructive cardiomyopathy (HOCM) with systolic anterior motion (SAM) in a patient, relieving symptoms. This procedure, performed with a permanent pacemaker, offers a beneficial therapeutic option for HOCM patients.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease characterized by left ventricular hypertrophy (LVH).
  • HCM is the most common genetic abnormality of the myocardium, with prevalence from 1:500 to 1:200.
  • It is a leading cause of sudden cardiac death (SCD) in young individuals and athletes.

Purpose of the Study:

  • To present a case of hypertrophic obstructive cardiomyopathy (HOCM) with systolic anterior motion (SAM).
  • To evaluate the efficacy of alcohol septal ablation (ASA) in treating HOCM with SAM.
  • To assess the role of a permanent pacemaker in conjunction with ASA.

Main Methods:

  • A 56-year-old male patient presented with exertional chest tightness and palpitations.
  • Diagnostic workup included echocardiography, cardiac magnetic resonance (CMR), coronary angiography (CAG), and left ventriculography.
  • Treatment involved alcohol septal ablation (ASA) under the protection of a permanent pacemaker.

Main Results:

  • Echocardiography revealed significant interventricular septal thickness (14-16 mm) and mitral valve SAM.
  • The patient experienced severe left ventricular outflow tract (LVOT) stenosis and moderate to severe mitral insufficiency.
  • Following ASA and pacemaker implantation, the patient's symptoms of chest tightness and palpitations resolved.

Conclusions:

  • Alcohol septal ablation (ASA) is a beneficial treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM) and systolic anterior motion (SAM).
  • The use of a permanent pacemaker provides protection during ASA.
  • This combined approach effectively resolved symptoms in the presented case.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
36
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
17
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22